Prostate Cancer
Role of lymphadenectomy for prostate cancer: Indications and controversies - Abstract
November 22, 2011
Personalized approach to prostate cancer prognosis - Abstract
November 22, 2011
Postoperative radiation therapy for pathologically advanced prostate cancer after radical prostatectomy - Abstract
November 21, 2011
The role of sipuleucel-T in therapy for castration-resistant prostate cancer: A critical analysis of the literature - Abstract
November 21, 2011
High-risk prostate cancer: Value of multi-modality 3T MRI-guided biopsies after previous negative biopsies - Abstract
November 21, 2011
Castration-resistant prostate cancer: Many treatments, many options, many challenges ahead - Abstract
November 21, 2011
Effect of constipation on serum total prostate-specific antigen levels in men - Abstract
November 21, 2011
Modifiable prostate cancer risk reduction and early detection behaviors in black men - Abstract
November 21, 2011
Prostate-cancer screening - what the U.S. Preventive Services Task Force left out - Abstract
November 18, 2011
One man at a time - resolving the PSA controversy - Abstract
November 18, 2011
Defining and predicting indolent and low risk prostate cancer - Abstract
November 18, 2011
Acute toxicity in prostate cancer patients treated with and without image-guided radiotherapy - Abstract
November 18, 2011
Image-guided dose-escalated intensity-modulated radiation therapy for prostate cancer: Treating to doses beyond 78 Gy - Abstract
November 18, 2011
Robot-assisted versus open radical prostatectomy: An evidence-based comparison - Abstract
November 17, 2011
Relationship of obesity, androgen receptor genotypes and biochemical failure after radical prostatectomy - Abstract
November 17, 2011
PSA doubling time predicts for the development of distant metastases for patients who fail 3DCRT Or IMRT using the Phoenix definition - Abstract
November 17, 2011